Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 99.9%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 100 shares, a drop of 99.9% from the January 31st total of 89,100 shares. Based on an average daily volume of 75,000 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Down 15.6 %

Shares of CNBX Pharmaceuticals stock traded down $0.00 during trading on Friday, hitting $0.01. 120,039 shares of the stock were exchanged, compared to its average volume of 86,672. CNBX Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.02. The stock’s fifty day moving average is $0.01 and its 200 day moving average is $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.